BRAF and cancer: Based on previous models of “polygenic” tumorigenesis in hypermutant cancers (39), we wondered whether the multiple BRAF and Ras pathway mutations in class 2 and 3 BRAF-mutant colorectal cancers were driven by a mutator phenotype.